Samsung, Biogen Co-Operate Amid Italian Antitrust Investigation Into Biosimilar Lucentis

Byooviz Biosimilar Not Available In Italy After August 2021 MAA; Conduct ‘Anomalous’

 
• By Dean Rudge
  
Many Hands Holding the Red Word Competition, Isolated
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation